Updates are available Correction dated 2022-07-11
Click to view Correction: https://doi.org/10.1186/s13023-022-02401-x
-
Authors
Howe, Sarah J. http://orcid.org/0000-0002-8578-497X
Lapidus, David
Hull, Michael
Yeaw, Jason
Stevenson, Tanya
Sampson, Jacinda B.
- License Information
-
More Information
Article History
Received: 18 October 2021
Accepted: 6 February 2022
First Online: 23 February 2022
Change Date: 11 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13023-022-02401-x
Declarations
:
: All data collection followed HIPAA and insurance industry standards.
: This manuscript contains no individual person’s data in any form.
: None of the authors have competing interests to report. SJH is an employee of the Marigold Foundation, a registered Canadian charity. DL is a consultant to the Marigold Foundation. MH is an employee of IQVIA, which was contracted by Marigold conduct the study. JY is an employee of IQVIA, which was contracted by Marigold to conduct the study. TS is an employee of the Myotonic Dystrophy Foundation. Scientific Advisor to Dyne Therapeutics, Expansion Therapeutics, and Viking Therapeutics. JS received research funding from the Marigold Foundation.
